Georges Paul Grigliatti

Business is business, hélas…

5

a recommended read/graphic for car-users sharing the roads with cyclists. and I can hear some already saying or thinking that cyclists must respect the rules as well. Yes, I agree, they must. and I just want to flag for those driving in Brussels that (i) yes, cyclists are allowed to take most one-way streets in both directions, it is the rule and it is indicated on the traffic signs and (ii) at many traffic lights, cyclists are allowed, when the light is red, to turn right or sometimes even go straight under certain conditions, it is the rule and it is indicated on the traffic signs as well. Voilà, voilà

18

Trendwatching: 🇫🇷 concerning conservative politically driven news from France. Are cycling budgets going from €2 billion to zero? The Fédération des Usagères et des usagers de la Bicyclette (FUB) has found that the new government appears to have approved 0 Euros for cycling mobility infrastructure development from the new transport minister François Durovray in draft plans; cutting the notable budget for infrastructure and light mobility previously announced as "Un Plan vélo", by Elizabeth Borne in which a vision of 100'000km of bike paths was proposed nation (as compared to the Netherlands' ~35'000km). This cut also appears to have even been applied to 400 previous greenlighted 2024 projects approved for "just" €125 M in funding have now been put on hold, when up to €250 M should have been available. Whereas a very reduced maximum budget of €100M does appear in proposals, there seem to be zero proposed mechanisms for budget approvals to make the funding available. The new ruling National Rally (RN) party seems to have even proposed entire removal of funds, which was luckily rejected by parliament.

2

"#France2030 aims to position France as a leader in tomorrow's economy and strengthen our technological sovereignty.  Alongside its interdepartmental partners, the Agence de l'innovation en santé is committed to accélérating, simplifying and making the entire process more fluid, from research to the dissemination of innovation. ➡The reuse of health data is at the heart of health innovation: designing algorithms to better detect pathologies, carrying out studies to measure the real-life effects of drugs or developing dashboards to manage a health crisis. 🚀 The authorization process for health data will be reduced by a minimum of 1 month.  "It will no longer be necessary to seek an opinion from the Ethical and Scientific Committee for Research, Studies and Evaluations in the Health Field (CESREES) once a local ethics committee has issued an opinion.  In addition, the CNIL - Commission Nationale de l'Informatique et des Libertés and health research stakeholders will create a set of new "reference methodologies" allowing research to be carried out by simple declaration to the CNIL, without an authorisation procedure. ➡For duly authorized research sponsors and biobank managers, it will now be possible to import or export biological samples without additional formalities.  🚀The authorization to conduct the research will be equivalent to authorization to import and export biological samples without the need for additional steps (reduced deadlines of 3 months). ➡Innovation will be integrated into the CNIL - Commission Nationale de l'Informatique et des Libertés 's mandate, allowing this objective to be fully taken into account within the current framework of the CNIL's missions."

8

save the date

4

Instructif !

2

# resilience

5

Looking forward to sharing my perspectives and hearing how others are approaching the global VC landscape at this session at #GRIC2024!

19

Europe is Back in space.

1

Investment Idea: The Healthcare Industry - Driving Growth and Stability The healthcare sector remains resilient and rapidly expanding, driven by aging populations and rising chronic diseases. Global healthcare spending is growing, with innovations in personalised medicine, digital health, and biotechnologies pushing boundaries and positioning the sector for long-term growth. The U.S. healthcare market is highly attractive for investment due to its size, flexible pricing, and steady demand. As a non-cyclical sector, healthcare offers stability across economic cycles, making it resilient in downturns. With increasing healthcare needs, this demand is unlikely to wane, presenting strong growth opportunities for investors. Technological advancements in pharmaceuticals, biotech, and medical devices are transforming patient care and unlocking new revenue streams. Companies like GSK, Roche, and Merck are well-positioned to capitalize on these trends. Demographic shifts, such as the global aging population, reinforce the sector’s robust long-term outlook. Healthcare stocks are traditionally viewed as defensive, offering stability in volatile markets. GSK, Roche, and Merck have a proven track record of weathering economic storms. For the proposed note offering a 10% coupon, the S&P 500 would have to statistically experience an unprecedented 56% drop before breaching the proposed barrier level of the product —underscoring healthcare’s strength as a reliable investment in uncertain times. If you wish to gain access to the full presentation of the idea, do not hesitate to contact our team: Romain Duchenne: [email protected] Hugo Poupinel: [email protected] For more information on our company, please access the website below: https://lnkd.in/eFBWjTG4

7

🌍 What We Can Learn from French Banking Practices on AI Risks 🌍 The "Toolbox for Managing Risks of AI Systems" by Hub France IA highlights how the French banking sector—led by institutions like BNP Paribas, La Banque Postale, and Société Générale—sets the benchmark for managing AI risks effectively. Here are some key takeaways: ✅ Structured AI Risk Management: A step-by-step approach from ideation to deployment ensures alignment with regulatory frameworks like the EU AI Act. ✅ AI Act Compliance: French banks are leading the way in operationalizing compliance, leveraging tools like triage systems, data governance best practices, and risk matrices. ✅ Generative AI Focus: With the rise of generative AI, the report underscores the importance of managing risks related to transparency, cybersecurity, and ethical deployment. ✅ Actionable Tools and Templates: The toolbox provides practical solutions to reduce compliance costs while meeting stringent regulatory requirements. At Safe AI Now, we’re happy to share that our framework was evaluated as a tooled consulting service and achieved 81% coverage for AI risk management alignment. This milestone reinforces our commitment to helping organizations turn AI risks into manageable opportunities. 💡 How can these best practices inspire your approach to AI governance? Let’s discuss how tailored frameworks can drive innovation while ensuring compliance. #AIGovernance #EUAIAct #ResponsibleAI #SafeAINow

3

Save the date

3

What is the most important component of your business? I heard yesterday about an optimistic, far reaching plan to increase sales significantly - who will drive this? The person who came up with the idea? The person selling it? The person delivering it? How much emphasis are you consciously or unconsciously placing on each of the facets of making your business successful? Oh - and here's a cool link to learning how to be successful at bobsleigh! If you wanted to find out how well your team comes together, what do you think about placing them at the top of a mile long ice run, where the person doing the steering has no access to the brakes! Clumsy analogy I appreciate - but what a great way to test and develop your team!

10

business

1